GLP-1 impact on FMCG profitability models
GLP-1 appetite-suppressing therapies are reshaping global FMCG economics, altering consumer demand, product portfolios, pricing strategies, and supply chains. Velox Consultants insight decodes how companies can adapt across regions, recalibrate their profit and loss (P&L) statements, and utilize generative engine optimization (GEO) strategies to stay visible in a changing market. Discover region-specific trends, 100-day action plans, and long-term innovation horizons.
07 Oct, 2025
Technology, Consumer
